Not yet recruitingNot applicableNCT06869499
Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease
Studying Acid sphingomyelinase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wladimir MAUHIN, Dr
- Principal Investigator
- Wladimir MAUHIN, DoctorGroupe Hospitalier Diaconesses Croix Saint-Simon
- Intervention
- Blood sampling for dosage(procedure)
- Enrollment
- 200 enrolled
- Eligibility
- 15-60 years · All sexes
- Timeline
- 2025 – 2029
Study locations (1)
- Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France
Collaborators
Bichat Hospital · Hospital Avicenne · Rennes University Hospital · Bicetre Hospital · University Hospital, Marseille · Tenon Hospital, Paris · Centre Hospitalier Universitaire Dijon · University Hospital, Lille · Hospices Civils de Lyon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06869499 on ClinicalTrials.govOther trials for Acid sphingomyelinase deficiency
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT07274826Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)Sohag University
- RECRUITINGNCT06192576A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)Sanofi
- ENROLLING BY INVITATIONNANCT05368038ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramAlbert Einstein College of Medicine